Dysport was FDA-approved for use in the US on April 30, 2009. At last, we have options for injectable wrinkle treatment! Dysport was originally to be marketed in the US under the name “Reloxin”, but the FDA decided that the original name should be used and did not allow the new name.
Heads Up, Botox: Bracing for a Challenge
Botox may soon face fierce competition when the F.D.A approves Dysport, another injectable made from the botulinum toxin, which has had success temporarily smoothing wrinkles.
The buzz among doctors that is spreading in the news media and on beauty-oriented websites such as skintastic.com is that Dysport works more quickly and lasts longer than the roughly four months Botox does.
In today’s economy, Dysport gives you a new choice in antiwrinkle treatment. The F.D.A. will most likely update Medicis in mid-April.
What exactly is Dysport?
Dysport is a simple, effective, non-surgical treatment that works by relaxing facial muscles on the forehead, thereby reducing and smoothing away frown-lines and wrinkles.